Page last updated: 2024-10-28

hydroxyurea and Hyperparathyroidism

hydroxyurea has been researched along with Hyperparathyroidism in 1 studies

Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

Research Excerpts

ExcerptRelevanceReference
"Hydroxyurea treatment, as well as and long- and short-acting narcotics were given, with little improvement in symptoms."1.33Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease. ( Abish, S; Albuquerque, P; Alyaarubi, S; Gale, M; Jabado, N; Krishnamoorthy, P, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krishnamoorthy, P1
Alyaarubi, S1
Abish, S1
Gale, M1
Albuquerque, P1
Jabado, N1

Other Studies

1 other study available for hydroxyurea and Hyperparathyroidism

ArticleYear
Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Pediatrics, 2006, Volume: 118, Issue:2

    Topics: Adenoma; Adolescent; Analgesics, Opioid; Anemia, Sickle Cell; Arthralgia; Back Pain; Bone Resorption

2006